Difference between revisions of "Avatrombopag (Doptelet)"
Jump to navigation
Jump to search
m (→Also known as) |
m |
||
| Line 4: | Line 4: | ||
==Diseases for which it is used== | ==Diseases for which it is used== | ||
*[[Immune thrombocytopenia (ITP)]] | *[[Immune thrombocytopenia (ITP)]] | ||
| − | |||
*[[Thrombocytopenia in liver disease]] | *[[Thrombocytopenia in liver disease]] | ||
==History of changes in FDA indication== | ==History of changes in FDA indication== | ||
| − | * 5/21/2018: FDA approved | + | * 5/21/2018: FDA approved for [[Thrombocytopenia in liver disease|thrombocytopenia in adults with chronic liver disease]] scheduled to undergo a procedure. |
==Also known as== | ==Also known as== | ||
Revision as of 00:22, 4 December 2018
Mechanism of action
Thrombopoietin receptor agonist
Diseases for which it is used
History of changes in FDA indication
- 5/21/2018: FDA approved for thrombocytopenia in adults with chronic liver disease scheduled to undergo a procedure.
Also known as
- Code names: E5501, YM477, AKR 501
- Brand name: Doptelet